List of Tables
    Table 1. Anti-inflammatory Biologics CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Anti-inflammatory Biologics Market Trends
    Table 3. Anti-inflammatory Biologics Market Drivers
    Table 4. Anti-inflammatory Biologics Market Challenges
    Table 5. Anti-inflammatory Biologics Market Restraints
    Table 6. Global Anti-inflammatory Biologics Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Anti-inflammatory Biologics Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Anti-inflammatory Biologics Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Anti-inflammatory Biologics Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Anti-inflammatory Biologics Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Anti-inflammatory Biologics Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Anti-inflammatory Biologics Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Anti-inflammatory Biologics Sales by Manufacturer, (K MT), 2017-2022
    Table 14. Global Anti-inflammatory Biologics Sales Share by Manufacturer, 2017-2022
    Table 15. Global Anti-inflammatory Biologics Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Anti-inflammatory Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Anti-inflammatory Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Biologics as of 2021)
    Table 18. Top Players of Anti-inflammatory Biologics in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Anti-inflammatory Biologics Product Type
    Table 20. Date of International Manufacturers Enter into Anti-inflammatory Biologics Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Anti-inflammatory Biologics Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Anti-inflammatory Biologics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Anti-inflammatory Biologics Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Anti-inflammatory Biologics Sales by Players, (K MT), 2020, 2021 & 2022
    Table 26. United States Anti-inflammatory Biologics Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Anti-inflammatory Biologics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Anti-inflammatory Biologics Sales in Volume by Region (2017-2022) & (K MT)
    Table 29. Global Anti-inflammatory Biologics Sales in Volume Forecast by Region (2023-2028) & (K MT)
    Table 30. Global Anti-inflammatory Biologics Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Anti-inflammatory Biologics Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Anti-inflammatory Biologics Sales in Volume by Country (2017-2028) & (K MT)
    Table 33. North America Anti-inflammatory Biologics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Anti-inflammatory Biologics Sales in Volume by Region (2017-2028) & (K MT)
    Table 35. Asia Pacific Anti-inflammatory Biologics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Anti-inflammatory Biologics Sales in Volume by Country (2017-2028) & (K MT)
    Table 37. Europe Anti-inflammatory Biologics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Anti-inflammatory Biologics Sales in Volume by Country (2017-2028) & (K MT)
    Table 39. Latin Americaa Anti-inflammatory Biologics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Anti-inflammatory Biologics Sales in Volume by Country (2017-2028) & (K MT)
    Table 41. Middle East and Africa Anti-inflammatory Biologics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. AbbVie Corporation Information
    Table 43. AbbVie Description and Business Overview
    Table 44. AbbVie Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. AbbVie Anti-inflammatory Biologics Product
    Table 46. AbbVie Recent Development
    Table 47. Johnson & Johnson Corporation Information
    Table 48. Johnson & Johnson Description and Business Overview
    Table 49. Johnson & Johnson Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. Johnson & Johnson Product
    Table 51. Johnson & Johnson Recent Development
    Table 52. Amgen Inc Corporation Information
    Table 53. Amgen Inc Description and Business Overview
    Table 54. Amgen Inc Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Amgen Inc Product
    Table 56. Amgen Inc Recent Development
    Table 57. AstraZeneca PLC Corporation Information
    Table 58. AstraZeneca PLC Description and Business Overview
    Table 59. AstraZeneca PLC Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. AstraZeneca PLC Product
    Table 61. AstraZeneca PLC Recent Development
    Table 62. Pfizer, Inc Corporation Information
    Table 63. Pfizer, Inc Description and Business Overview
    Table 64. Pfizer, Inc Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Pfizer, Inc Product
    Table 66. Pfizer, Inc Recent Development
    Table 67. Novartis Corporation Information
    Table 68. Novartis Description and Business Overview
    Table 69. Novartis Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. Novartis Product
    Table 71. Novartis Recent Development
    Table 72. Roche Corporation Information
    Table 73. Roche Description and Business Overview
    Table 74. Roche Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. Roche Product
    Table 76. Roche Recent Development
    Table 77. Sun Pharmaceutical Industries Ltd Corporation Information
    Table 78. Sun Pharmaceutical Industries Ltd Description and Business Overview
    Table 79. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 80. Sun Pharmaceutical Industries Ltd Product
    Table 81. Sun Pharmaceutical Industries Ltd Recent Development
    Table 82. Sanofi Corporation Information
    Table 83. Sanofi Description and Business Overview
    Table 84. Sanofi Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 85. Sanofi Product
    Table 86. Sanofi Recent Development
    Table 87. GlaxoSmithKline Corporation Information
    Table 88. GlaxoSmithKline Description and Business Overview
    Table 89. GlaxoSmithKline Anti-inflammatory Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 90. GlaxoSmithKline Product
    Table 91. GlaxoSmithKline Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Anti-inflammatory Biologics Customers List
    Table 95. Anti-inflammatory Biologics Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-inflammatory Biologics Product Picture
    Figure 2. Global Anti-inflammatory Biologics Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Anti-inflammatory Biologics Market Size 2017-2028 (US$ Million)
    Figure 4. Global Anti-inflammatory Biologics Sales 2017-2028 (K MT)
    Figure 5. United States Anti-inflammatory Biologics Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Anti-inflammatory Biologics Market Size 2017-2028 (US$ Million)
    Figure 7. United States Anti-inflammatory Biologics Sales 2017-2028 (K MT)
    Figure 8. United States Anti-inflammatory Biologics Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Anti-inflammatory Biologics Market Share in Global, in Volume (K MT) 2017-2028
    Figure 10. Anti-inflammatory Biologics Report Years Considered
    Figure 11. Product Picture of Synthetic Type
    Figure 12. Product Picture of Biological Type
    Figure 13. Global Anti-inflammatory Biologics Market Share by Type in 2022 & 2028
    Figure 14. Global Anti-inflammatory Biologics Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Anti-inflammatory Biologics Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Anti-inflammatory Biologics Sales by Type (2017-2028) & (K MT)
    Figure 17. Global Anti-inflammatory Biologics Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Anti-inflammatory Biologics Price by Type (2017-2028) & (USD/MT)
    Figure 19. United States Anti-inflammatory Biologics Market Share by Type in 2022 & 2028
    Figure 20. United States Anti-inflammatory Biologics Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Anti-inflammatory Biologics Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Anti-inflammatory Biologics Sales by Type (2017-2028) & (K MT)
    Figure 23. United States Anti-inflammatory Biologics Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Anti-inflammatory Biologics Price by Type (2017-2028) & (USD/MT)
    Figure 25. Product Picture of Arthritis
    Figure 26. Product Picture of Respiratory Diseases
    Figure 27. Product Picture of Dermatology
    Figure 28. Product Picture of Gastroenterology
    Figure 29. Product Picture of Others
    Figure 30. Global Anti-inflammatory Biologics Market Share by Application in 2022 & 2028
    Figure 31. Global Anti-inflammatory Biologics Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 32. Global Anti-inflammatory Biologics Sales Market Share in Value by Application (2017-2028)
    Figure 33. Global Anti-inflammatory Biologics Sales by Application (2017-2028) & (K MT)
    Figure 34. Global Anti-inflammatory Biologics Sales Market Share in Volume by Application (2017-2028)
    Figure 35. Global Anti-inflammatory Biologics Price by Application (2017-2028) & (USD/MT)
    Figure 36. United States Anti-inflammatory Biologics Market Share by Application in 2022 & 2028
    Figure 37. United States Anti-inflammatory Biologics Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 38. United States Anti-inflammatory Biologics Sales Market Share in Value by Application (2017-2028)
    Figure 39. United States Anti-inflammatory Biologics Sales by Application (2017-2028) & (K MT)
    Figure 40. United States Anti-inflammatory Biologics Sales Market Share in Volume by Application (2017-2028)
    Figure 41. United States Anti-inflammatory Biologics Price by Application (2017-2028) & (USD/MT)
    Figure 42. North America Anti-inflammatory Biologics Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 43. North America Anti-inflammatory Biologics Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 44. U.S. Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Canada Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Europe Anti-inflammatory Biologics Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 47. Europe Anti-inflammatory Biologics Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. Germany Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. France Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. U.K. Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Italy Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Russia Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Asia-Pacific Anti-inflammatory Biologics Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 54. Asia-Pacific Anti-inflammatory Biologics Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 55. China Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Japan Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. South Korea Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. India Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Australia Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Taiwan Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Indonesia Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Thailand Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Malaysia Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Philippines Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Latin America Anti-inflammatory Biologics Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 66. Latin America Anti-inflammatory Biologics Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 67. Mexico Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Brazil Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Argentina Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Middle East & Africa Anti-inflammatory Biologics Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 71. Middle East & Africa Anti-inflammatory Biologics Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 72. Turkey Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Saudi Arabia Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. U.A.E Anti-inflammatory Biologics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. Anti-inflammatory Biologics Value Chain
    Figure 76. Anti-inflammatory Biologics Production Process
    Figure 77. Channels of Distribution
    Figure 78. Distributors Profiles
    Figure 79. Bottom-up and Top-down Approaches for This Report
    Figure 80. Data Triangulation
    Figure 81. Key Executives Interviewed